Neogenomics Inc (NEO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché NEO Giù? Forum Previsione Frazionamento azionario

Neogenomics Inc Azioni (NEO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1.26% 190.17	187.80	181.33	168.03	172.00
Cost Of Revenue	0.49% 106.83	107.35	104.07	94.79	94.74
Gross Profit	3.60% 83.34	80.45	77.26	73.25	77.26
Operating Expenses	9.96% 96.76	107.46	124.89	101.07	95.66
Benefits Costs and Expenses	5.42% 202.58	214.19	227.15	193.69	188.13
Costs And Expenses	5.42% 202.58	214.19	227.15	193.69	188.13
Operating Income/Loss	50.34% -13.41	-27.01	-47.63	-27.82	-18.40
Income/Loss From Continuing Operations Before Tax	52.99% -12.41	-26.39	-45.82	-25.66	-16.13
Income Tax Expense/Benefit	441.22% -2.525	0.74	-0.724	0.266	-0.804
Income/Loss From Continuing Operations After Tax	63.58% -9.881	-27.13	-45.09	-25.92	-15.32
Net Income/Loss	63.58% -9.881	-27.13	-45.09	-25.92	-15.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.86% 0.184	128.41	127.95	127.38	0.167
Diluted Average Shares	99.86% 0.184	128.41	127.95	127.38	0.167
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

DGX

$196.46

0.19%

$266.02

0.04%

MTD

$1,265.75

0.10%

IQV

$165.64

0.27%

NTRA

$197.37

1.47%

WAT

$302.32

0.13%